We found that prior biopsy and atypical hyperplasia were strongly associated with ER/PR+cancers irrespective of HER2 status but were not associated with TNBC, recognizing that the HR for the association with for ER/PR−HER2+ was relatively large but not statistically significant. The gene discussed is ESR1; the disease is cancer.